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Introduction
Cerebral blood flow (CBF) is autoregulated, i.e. kept con-
stant during fluctuations in systemic blood pressure within 
wide limits. If blood pressure falls below the lower limit of 
autoregulation, CBF decreases, and if blood pressure rises 
above the upper limit of autoregulation, CBF increases.1,2 
The renin–angiotensin system (RAS) exerts a tone in the 
resistance vessels of the brain. Inhibition of this system with 
either an angiotensin converting enzyme inhibitor (ACEi) 
or an angiotensin receptor blocker (ARB) shifts the lower 
and upper limits of autoregulation of CBF towards lower 
blood pressure levels. This has been shown with the ACEis 
captopril, ceranopril, fosinopril, and enalapril,3–5 and the 
ARBs candesartan and valsartan,5–7 that block the angioten-
sin II subtype 1 (AT1) receptor. We found that a single dose 
of candesartan caused a significant shift of the lower limit of 
the order of 7 mmHg in Sprague-Dawley rats fed standard 
chow with a sodium content of 0.25%.5
Plasma renin activity (PRA) is influenced by changes in 
the sodium content of the diet, high sodium intake resulting 
in low PRA and low sodium intake in high PRA.8 In a previ-
ous study our group has shown that the effect the ACEi cap-
topril on the lower limit of CBF autoregulation is not 
dependent on the presence of circulating renin.9 Further we 
have shown that the ARB candesartan had the same effect 
on CBF autoregulation as the ACEi captopril.5 The aim of 
the present study was to investigate the influence of the 
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Abstract
Autoregulation of cerebral blood flow (CBF) denotes that CBF is constant despite fluctuation of blood pressure within 
wide limits. Inhibition of the renin–angiotensin system (RAS) is known to decrease the lower and upper limits of CBF 
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ARB candesartan on the lower limit of CBF autoregulation 
when manipulating the renin activity by changes in sodium 
intake. It was hypothesized that a low salt intake/high renin 
activity would conserve or even amplify the effect of cande-
sartan blocking the effect of renin; while a high salt intake/
low renin activity might suppress or even abolish the effect.
Methods
Studies of CBF autoregulation were carried out in male 
Sprague-Dawley rats, weight about 250 g, corresponding to 
an age of 50 days, obtained from Charles River, Germany. 
All procedures were conducted in accordance with the 
FELASA guidelines for animal research and approved by 
The Danish Animal Experiments Inspectorate (license num-
ber 2007/561-1320) as well as by The Department of 
Experimental Medicine at The Faculty of Health and 
Medical Sciences, the University of Copenhagen. The study 
is reported in accordance with ARRIVE guidelines.
Groups of animals, chow, and medication
The animals were divided into two main groups: (1) a group 
fed high sodium diet (4.0% Na+); (2) a group fed low sodium 
diet (0.004% Na+). The diets were given for 7 days and were 
supplied by Brogaarden, Denmark and Zeigler, USA, 
respectively. All the animals had unlimited access to drink-
ing water. Both main groups were further divided into a con-
trol group and a group that was given a single dose of the 
ARB candesartan (AstraZeneca, Sweden) 0.2 mg/kg intra-
venously as an infusion lasting two min. This is the same 
dose as in our previous study on CBF autoregulation.5 
Thirty-two animals were investigated, eight in each group. 
To prevent clotting of the catheters all animals were given 
200 IE of heparin intravenously.
An additional group of six animals on normal salt 
intake only received candesartan 0.2 mg/kg and blood 
pressure was followed for 2 h. This group was studied 
only to demonstrate a biological effect of candesartan. No 
other procedures were performed and only blood pressure 
was measured.
Surgical procedures
All animals were studied under general anesthesia with 
isoflurane (Baxter, USA) and N2O. During induction the 
dose of isoflurane was 5%, while it was set to 2.5% during 
surgery and 1.7% during CBF measurements. No muscle 
relaxant was given. A tube was surgically placed in the tra-
chea for mechanical ventilation. Polyethylene catheters 
were inserted in both femoral arteries and both femoral 
veins. One arterial catheter was used for monitoring blood 
pressure and the other for arterial blood sampling to moni-
tor pO2 and pCO2. One of the venous catheters was used 
for drug infusion. After the insertion of the catheters the 
animal was placed in a stereotactic apparatus. With a small 
dental drill a craniotomy was done and care was taken not 
to damage the dura that was kept intact. A laser Doppler 
probe was placed onto the dura away from the larger ves-
sels, to measure CBF.
Measurements and data analysis
After induction of anesthesia and before surgical interven-
tion, venous blood was sampled from a tail vein (60 µL) 
and analyzed for K+, Na+, urea, and creatinine by standard 
clinical chemistry methods at the department of clinical 
chemistry at our hospital, and for analysis of plasma renin 
concentrations (PRCs).
PRC was measured by the rate of generation of 
Angiotensin I in the presence of excess angiotensinogen 
by the antibody trapping method,10 modified as previously 
described by one of the authors.11 Angiotensinogen excess 
was obtained by addition of plasma from nephrectomized 
sheep. Results are reported as milli international units per 
liter (mIU/L) of the activity of the standard WHO renin 
sample (National Institute for Biological Standards and 
Control, Hertfordshire, UK) measured along with the 
plasma samples in each assay.
Baseline blood pressure was recorded in all animals fol-
lowing anesthesia and placement of catheters in the femo-
ral arteries and veins, but before craniotomy and medication 
with norepinephrine and candesartan.
To prevent an initial fall in blood pressure below the 
lower limit of the autoregulation of CBF during and after 
craniotomy, norepinephrine 0.5–9 µg/min was infused intra-
venously keeping mean arterial blood pressure (MABP) sta-
ble at about 85–100 mmHg. Intravenous norepinephrine 
will not influence CBF.2 Thereafter an intravenous injection 
of candesartan (lasting 2 min) was given. During the follow-
ing 20 min blood pressure stabilized at a lower level. Then 
the experiment continued with sequentially reducing and 
finally discontinuing the norepinephrine infusion, followed 
by controlled stepwise bleeding to lower the blood pressure 
(Figure 1). A waiting period of about 2 min ensued after 
every reduction in norepinephrine infusion and later between 
the controlled bleeding that was between 0.1 and 0.2 mL at 
a time to make certain that a new steady state in both MABP 
and CBF was achieved. The whole procedure lowering the 
blood pressure took about 45 min. Arterial blood samples 
were collected to measure pO2 and pCO2 at the start and at 
the end of the experiment. Initial hemoglobin levels were 
measured in the first arterial blood sample. The respirator 
was adjusted as necessary to maintain stable pCO2. Data 
were collected on a PC running MS Windows 98 SE run-
ning Perisoft 2.5 via Periflux 5000 and a PF 472 A/D 
Converter Box from Perimed AB, Sweden.
The laser Doppler flowmetry has been validated at our 
laboratory for estimating the lower limit of CBF autoregula-
tion,12 and has been used in several disease models.13–15 The 
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equipment continuously monitored local cortical cerebral 
perfusion by multiple measurements (Figure 1). From the 
laser Doppler signal a relative value for CBF is calculated 
and expressed as per cent of baseline. The method does not 
give absolute CBF values, but relative flow in arbitrary units.
The lower limit is defined as the intersection between a 
slope regression line which represents the measured levels 
clearly below the lower limit and a plateau regression line 
which in turn represents the measurements above the lower 
limit. The lines are found by including additional measure-
ments in the slope until a best fit is found, defined as the 
least sum of squares of the deviations from the different sets 
of lines. The method of calculation represents a modifica-
tion of the method described in detail in a previously pub-
lished paper.9 In that paper a horizontal line was used to fit 
the plateau, but here we allowed this line to have a slope 
(Figure 2). Constraints on the intersection point were used 
on the slope as described previously,9 but their significance 
is minor in the present study which included multiple meas-
uring points and thereby better-defined slopes. The program 
used to calculate the lower limit was a DOS program that 
was run on a MacBook Pro running OS X 10.6.2 and emu-
lating DOS using DOSBox v.0.73. Statistical analysis was 
done on a MacBook Pro running OS X 10.6.2 using Prism 
5.0c. Data were analyzed with one-way analysis of variance 
(ANOVA) followed by Tukey’s multiple comparison test to 
compare the four groups to each other. A t-test was used to 
compare variables between the high sodium and low sodium 
groups, and to compare variables between control and can-
desartan within each group.
Results
There was no difference among the animal groups in pCO2 
and pO2 levels during CBF measurements. Data for arte-
rial blood gases and lower limits of CBF autoregulation 
are shown in Tables 1 and 2. Biochemical variables are 
shown in Table 3. Animals on low sodium diet had raised 
PRC compared to the animals on high sodium diet. In the 
low sodium animals, Na+ levels were lower compared to 
the animals on high sodium diet whereas urea, creatinine 
and hemoglobin levels were raised. K+ levels were not sta-
tistically different. Data for biochemical variables are 
shown in Table 3. The animals in the high sodium group 
gained more weight and MABP was lower in the high 
sodium group after induction of anesthesia compared to 
the animals on low sodium diet. The high sodium animals 
consumed water in much greater amounts than the animals 
in the low sodium group and urinary output was corre-
spondingly larger (not measured quantitatively). Data for 
weight and blood pressure are shown in Table 4.
There was no significant difference between the lower 
limit of autoregulation in the four groups of rats where 
CBF was monitored, and especially no tendency to a lower 
limit following candesartan in neither the high nor the low 
salt intake groups. Both high sodium and low sodium diets 
thus appeared to block the effect of candesartan on the 
lower limit found in an earlier study.6
In the additional group of animals only receiving one 
dose of candesartan identical for all animals, a clear-cut 
biological effect was demonstrated. MABP dropped from 
about 90 to about 50 mmHg following candesartan and 
remained at that level for 2 h (Figure 3).
Discussion
The finding that there was no difference in the lower limit 
of CBF autoregulation during blockade of the AT1 recep-
tor in any of the four animal groups was not predicted, as 
Figure 1. Time course of mean blood pressure (MABP) and 
cerebral blood flow (CBF) illustrated in a single animal.
Figure 2. The lower limit of autoregulation of cerebral 
blood flow. All simultaneous measurement of CBF and blood 
pressure are shown from a single animal study. Two slopes are 
calculated one for the points below and one for those above 
a chosen point among the measurements. Calculating for all 
measurement points, the slopes yielding the best fit (lowest 
sum of square) are used, and the lower limit of autoregulation 
is defined as the intersection between the two slopes.
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it was anticipated that candesartan would cause a shift in 
the lower limit of CBF autoregulation to the left towards 
lower blood pressure levels. This was observed in our 
recent study where we administrated candesartan to rats on 
normal diet.5 Further, our group has previously shown that 
the effect of the ACEi captopril on autoregulation of CBF 
is independent of circulating renin. This was shown in rats 
that were kept alive with peritoneal dialysis for 48 h after 
bilateral nephrectomy. At that point circulating renin was 
no longer present, but the shift of the lower limit of CBF 
autoregulation to the left, towards lower blood pressure 
was preserved during ACEi with captopril, most likely due 
to an effect on the RAS in the vessel wall.9 A similar effect 
on the lower limit of CBF autoregulation was expected in 
animals that had very low PRC due to high sodium intake. 
Vessel wall renin, on the other hand, would also expect-
edly be suppressed in these animals, and the lack of effect 
of candesartan on the lower limit of CBF autoregulation in 
high salt animals may simply be due to the suppression of 
the RAS leaving no room for pharmacological blockade.
Low sodium diet increased PRC as expected, but con-
trary to expectation candesartan had no effect on the lower 
limit in these animals either. Low sodium intake increases 
sympathetic activity in man and rat.16,17 High sympathetic 
Table 1. Arterial blood gases.













start pCO2 (kPa) 4.7 ± 0.20 5.1 ± 0.20 4.9 ± 0.21 4.9 ± 0.46
end pCO2 (kPa) 5.0 ± 0.22 5.1 ± 0.26 4.9 ± 0.21 5.1 ± 0.37
start pO2 (kPa) 19.9 ± 5.22 19.2 ± 2.91 20.3 ± 2.90 18.3 ± 1.23
end pO2 (kPa) 20.3 ± 5.81 21.1 ± 2.98 23.0 ± 2.69 21.3 ± 2.29
“Start” and “end” refer to values at the beginning and the end of the measurement of the autoregulatory curve.
No significant differences with multiple comparison (ANOVA) test.
Table 2. Lower limit of CBF autoregulation.













Lower limit of CBF autoregulation (mmHg) 37 ± 10* 44 ± 13* 41 ± 14 40 ± 6
No significant differences with multiple comparison (ANOVA) test or t-test within each sodium group.
Table 3. Biochemical variables.









 N = 6 N = 8 N = 6 N = 6
K+ (mmol/L) 4.3 ± 0.47 3.9 ± 0.59 4.1 ± 0.19 4.1 ± 0.27
Na+ (mmol/L) * 148 ± 2.73 148 ± 0.92 144 ± 1.03 143 ± 0.98
Creatinine (mmol/L) § 13.6 ± 2.81 10.9 ± 0.75 16.5 ± 3.33 16.3 ± 4.43
Urea (mmol/L) * 5.2 ± 0.65 5.0 ± 0.47 7.5 ± 2.03 8.5 ± 2.73
 N = 8 N = 8 N = 8 N = 8
Hgb (mmol/L) * 7.6 ± 0.38 7.4 ± 0.60 8.6 ± 0.32 8.1 ± 0.58
PRC (mIU/L) * 11.1 ± 3.40 8.9 ± 2.45 70.1 ± 20.03 77.3 ± 36.94
Hgb: hemoglobin; PRC: plasma renin concentration.
Statistics:
(1) High sodium vs. low sodium chow, with controls and candesartan pooled together: *p < 0.0001, §p < 0.005 in t-test.
(2) High sodium: candesartan vs. control. No statistically significant differences.
(3) Low sodium: candesartan vs. control: for Hgb p < 0.05.
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activity was most likely also present in the low-salt ani-
mals of the present study, given the surprising finding that 
blood pressure under anesthesia was on average 19 mmHg 
higher in low-salt than in high-salt animals despite signs of 
a reduced extracellular volume in the former. In these ani-
mals, a marked alpha-adrenergic sympathetic effect on the 
“inflow tract” arteries may have overridden the effect of 
the RAS and its blockade on the lower limit. Interestingly, 
stimulation of the sympathetic cervical ganglia has been 
shown to eliminate the effect of captopril on the upper 
limit of CBF autoregulation.18
In the present study, the high and very low sodium 
chow was given for one week before studying CBF 
autoregulation. In rats, increases in indices of oxidative 
stress may occur as a result of administration of doses of 
AngII mimicking activation of the renin system,19 as well 
as of a high-sodium diet associated with suppression of the 
renin system.20 It is possible, therefore, that elevated oxi-
dative stress may be a common denominator underlying 
the present results. However, separate studies are required 
to elucidate this intriguing possibility.
There were several signs of expected changes in body 
fluid volume in the animals, in contrast to the paradoxical 
difference in blood pressure. In low-sodium animals, 
hemoglobin, creatinine and urea were significantly ele-
vated compared to the high-sodium animals. This most 
likely represents intravascular depletion with reduced 
intravascular volume which leads to reduced kidney func-
tion and thereby elevated creatinine levels. It is well known 
that in rats, sodium restriction leads to marked reductions 
in glomerular filtration rate.21,22 In the high-sodium ani-
mals, a significant increase in body weight was observed 
during the one week of diet. They also had an increased 
water consumption compared to the low-sodium animals, 
although the exact fluid intake and urinary output was not 
measured. Hence, the low-sodium animals expectedly 
would have a lowered extracellular volume and high-
sodium animals an increased extracellular volume. 
However, it is unlikely that these changes influenced CBF 
and its autoregulation.
Finally, a type 2 error should be considered as a possi-
ble due to the limited number of animals in the present 
study. We do however find this unlikely as the results from 
our study do not show any trend at all towards significant 
difference between the two groups that were either fed 
high or low sodium chow or in the four subgroups that 
were treated with the ARB or were not treated.
Clinical implications from the present study ought to be 
drawn with precautions. Although it is widely accepted that 
salt intake should be reduced in hypertension a strict relation 
between salt intake and cardiovascular mortality is lacking 
firm evidence and a tendency to an inverse relationship has 
even been observed.23 In the present study a very low salt 
intake was applied (0.004%) and such low salt intake are 
hardly seen in the clinical setting. Still our result leads to 
Table 4. Weight and blood pressure.














of special chow (g)
238 ± 24.06 235 ± 8.01 237 ± 10.95 246 ± 20.43
Weight at day
of experiment (g)
259 ± 22.24 258 ± 9.46 249 ± 7.04 264 ± 19.27
Weight gain (%) * 8.91 ± 4.07 9.73 ± 3.36 5.25 ± 2.29 7.75 ± 2.81
MABP (mmHg) * 83 ± 12.10 84 ± 16.48 104 ± 8.00 99 ± 15.84
MABP: mean arterial blood pressure measured after anesthesia, but before craniotomy and medication with norepinephrine and candesartan.
Statistics:
(1) High sodium vs. low sodium chow, with controls and candesartan pooled together: * p < 0.05 in t-test.
(2) High sodium: candesartan vs. control. No statistically significant differences.
(3) Low sodium: candesartan vs. control. No statistically significant differences.
Figure 3. The isolated effect of candesartan on the arterial 
blood pressure. No other medication or intervention was 
applied. Mean arterial blood pressure dropped from about 90 
mmHg to about 50 mmHg following candesartan and remained 
at that level for 2 h.
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precaution regarding massive reduction in salt intake in 
patients and calls for further clinical investigations.
Conclusion
Both high and low sodium diet eliminated the effect of the 
ARB candesartan on the lower limit of CBF autoregula-
tion. The precise mechanisms for this are unclear, but we 
propose the following explanations: In the low-sodium 
group, blood pressure was almost 20 mmHg higher under 
anesthesia than in the high-sodium group, most likely 
because of alpha-adrenergic sympathetic activation. Such 
activation might override the effect of the RAS and its 
blockade, explaining the lack of effect of candesartan. In 
the high-sodium group, the RAS may have been so sup-
pressed that it was not able to react to pharmacological 
blockade, explaining the lack of candesartan in this group. 
Clearly, further studies are necessary to confirm and 
explain the observations of the present work.
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